Form 4 Filing for CASI Pharmaceuticals, Inc.

This filing details the ownership of CASI Pharmaceuticals, Inc. (CASIF) ordinary shares by Wei-Wu He. It includes direct holdings of ordinary shares and options to buy, as well as indirect holdings through various entities such as Emerging Technology Partners, LLC, ETP Global Fund. L.P., ETP BioHealth III Fund, L.P., HE Family GRAT, and Huiying Memorial Foundation. The filing also discloses convertible notes with specific conversion price ranges and expiration dates. Dr. He is identified as a ten percent owner and director of the company. The report is dated March 18, 2026.